159 related articles for article (PubMed ID: 30779620)
1. Outcomes and adverse effects associated with stereotactic body radiation therapy in dogs with nasal tumors: 28 cases (2011-2016).
Mayer MN; DeWalt JO; Sidhu N; Mauldin GN; Waldner CL
J Am Vet Med Assoc; 2019 Mar; 254(5):602-612. PubMed ID: 30779620
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic body radiation therapy for treatment of soft tissue sarcomas in 35 dogs.
Gagnon J; Mayer MN; Belosowsky T; Mauldin GN; Waldner CL
J Am Vet Med Assoc; 2020 Jan; 256(1):102-110. PubMed ID: 31841095
[TBL] [Abstract][Full Text] [Related]
3. Outcome of stereotactic body radiation for treatment of nasal and nasopharyngeal lymphoma in 32 cats.
Reczynska AI; LaRue SM; Boss MK; Lee BI; Leary D; Pohlmann K; Griffin L; Lana S; Wormhoudt Martin T
J Vet Intern Med; 2022 Mar; 36(2):733-742. PubMed ID: 35188694
[TBL] [Abstract][Full Text] [Related]
4. Use of an image-guided robotic radiosurgery system for the treatment of canine nonlymphomatous nasal tumors.
Glasser SA; Charney S; Dervisis NG; Witten MR; Ettinger S; Berg J; Joseph R
J Am Anim Hosp Assoc; 2014; 50(2):96-104. PubMed ID: 24446402
[TBL] [Abstract][Full Text] [Related]
5. Outcome of intensity-modulated radiation therapy-based stereotactic radiation therapy for treatment of canine nasal carcinomas.
Fox-Alvarez S; Shiomitsu K; Lejeune AT; Szivek A; Kubicek L
Vet Radiol Ultrasound; 2020 May; 61(3):370-378. PubMed ID: 32189433
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiation therapy for treatment of injection-site sarcomas in cats: 11 cases (2008-2012).
Nolan MW; Griffin LR; Custis JT; LaRue SM
J Am Vet Med Assoc; 2013 Aug; 243(4):526-31. PubMed ID: 23902446
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic body radiation therapy for heart-base tumors in six dogs.
Magestro LM; Gieger TL; Nolan MW
J Vet Cardiol; 2018 Jun; 20(3):186-197. PubMed ID: 29724584
[TBL] [Abstract][Full Text] [Related]
8. Survival times for canine intranasal sarcomas treated with radiation therapy: 86 cases (1996-2011).
Sones E; Smith A; Schleis S; Brawner W; Almond G; Taylor K; Haney S; Wypij J; Keyerleber M; Arthur J; Hamilton T; Lawrence J; Gieger T; Sellon R; Wright Z
Vet Radiol Ultrasound; 2013; 54(2):194-201. PubMed ID: 23278974
[TBL] [Abstract][Full Text] [Related]
9. Linac-based stereotactic radiation therapy for canine non-lymphomatous nasal tumours: 29 cases (2013-2016).
Gieger TL; Nolan MW
Vet Comp Oncol; 2018 Mar; 16(1):E68-E75. PubMed ID: 28741887
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of dogs with thymoma treated with intensity modulated stereotactic body radiation therapy or non-modulated hypofractionated radiation therapy.
Trageser E; Martin T; Hoaglund E; Leary D; LaRue S; Boss MK
Vet Comp Oncol; 2022 Jun; 20(2):491-501. PubMed ID: 34936172
[TBL] [Abstract][Full Text] [Related]
11. A retrospective analysis of stereotactic body radiation therapy for canine heart base tumors: 26 cases.
Kruckman-Gatesy CR; Ames MK; Griffin LR; Boss MK; Rao S; Leary D; LaRue SM
J Vet Cardiol; 2020 Feb; 27():62-77. PubMed ID: 32078943
[TBL] [Abstract][Full Text] [Related]
12. OUTCOMES AND PROGNOSTIC FACTORS ASSOCIATED WITH CANINE SINONASAL TUMORS TREATED WITH CURATIVE INTENT CONE-BASED STEREOTACTIC RADIOSURGERY (1999-2013).
Kubicek L; Milner R; An Q; Kow K; Chang M; Cooke K; Fox L; Farese J; Bacon N; Lurie D
Vet Radiol Ultrasound; 2016 May; 57(3):331-40. PubMed ID: 26880676
[TBL] [Abstract][Full Text] [Related]
13. Myositis following spine radiosurgery for metastatic disease: a case series.
Lockney DT; Jia AY; Lis E; Lockney NA; Liu C; Hopkins B; Higginson DS; Yamada Y; Laufer I; Bilsky M; Schmitt AM
J Neurosurg Spine; 2018 Apr; 28(4):416-421. PubMed ID: 29372858
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy.
Altwal J; Lee BI; Boss MK; LaRue SM; Martin TW
Vet Comp Oncol; 2024 Mar; 22(1):125-135. PubMed ID: 38246695
[TBL] [Abstract][Full Text] [Related]
15. Single fraction stereotactic radiation therapy (stereotactic radiosurgery) is a feasible method for treating intracranial meningiomas in dogs.
Kelsey KL; Gieger TL; Nolan MW
Vet Radiol Ultrasound; 2018 Sep; 59(5):632-638. PubMed ID: 29873144
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy of malignant nasal tumors in 67 dogs.
Adams WM; Withrow SJ; Walshaw R; Turrell JM; Evans SM; Walker MA; Kurzman ID
J Am Vet Med Assoc; 1987 Aug; 191(3):311-5. PubMed ID: 3654292
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival with stereotactic radiotherapy for imaging-diagnosed pituitary tumors in dogs.
Hansen KS; Zwingenberger AL; Théon AP; Kent MS
Vet Radiol Ultrasound; 2019 Mar; 60(2):219-232. PubMed ID: 30575174
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of tumor volume reduction of nasal carcinomas versus sarcomas in dogs treated with definitive fractionated megavoltage radiation: 15 cases (2010-2016).
Morgan MJ; Lurie DM; Villamil AJ
BMC Res Notes; 2018 Jan; 11(1):70. PubMed ID: 29361976
[TBL] [Abstract][Full Text] [Related]
19. Outcome of definitive fractionated radiation followed by exenteration of the nasal cavity in dogs with sinonasal neoplasia: 16 cases.
Bowles K; DeSandre-Robinson D; Kubicek L; Lurie D; Milner R; Boston SE
Vet Comp Oncol; 2016 Dec; 14(4):350-360. PubMed ID: 25178539
[TBL] [Abstract][Full Text] [Related]
20. A retrospective study of sinonasal tumors in 182 dogs treated with stereotactic radiotherapy (3 × 10 Gy) (2010-2015).
Yoshikawa H; Lafferty MH; Griffin LR; LaRue SM
J Vet Intern Med; 2023; 37(6):2356-2367. PubMed ID: 37688322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
